Cargando…
The Biological Function of TUSC7/miR-1224-3p Axis in Triple-Negative Breast Cancer
BACKGROUND: Triple-negative breast cancers (TNBC), comprising about 20% of breast cancers, have a poor prognosis. Currently, there is no effective target therapy for TNBC. LncRNA TUSC7 has been identified as a tumor suppressor in osteosarcoma and colorectal cancer. In this study, we investigated the...
Autores principales: | Zheng, Bo-Hao, He, Zhi-Xian, Zhang, Juan, Ma, Jing-Jing, Zhang, Hong-Wei, Zhu, Wei, Shao, Zhi-Min, Ni, Xiao-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296971/ https://www.ncbi.nlm.nih.gov/pubmed/34305410 http://dx.doi.org/10.2147/CMAR.S305865 |
Ejemplares similares
-
Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211
por: Cong, Menglin, et al.
Publicado: (2019) -
LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1
por: Chang, Zhi-wei, et al.
Publicado: (2018) -
Effects of lncRNA TUSC7 on the malignant biological behavior of osteosarcoma cells via regulation of miR-375
por: Wang, Lulu, et al.
Publicado: (2020) -
lncRNA TUSC7 inhibits osteosarcoma progression through the miR-181a/RASSF6 axis
por: Zhao, Aiqing, et al.
Publicado: (2021) -
miR-497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR-588/TUSC1 axis
por: Ji, Li-Ya, et al.
Publicado: (2021)